Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, January 2009, p. 312-315, Vol. 53, No. 1
0066-4804/09/$08.00+0 doi:10.1128/AAC.00988-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Department of Histology, Microbiology and Medical Biotechnologies, University of Padova, 35121 Padua, Italy,1 Department of Chemistry and Technology of Drugs, University of Perugia, 06123 Perugia, Italy2
Received 24 July 2008/ Returned for modification 6 September 2008/ Accepted 5 November 2008
We identified a 6-aminoquinolone compound, WC5, that inhibits human cytomegalovirus (HCMV) replication with a selectivity index of
500. WC5 also showed activity against drug-resistant HCMV strains. In contrast, it did not significantly affect the replication of human herpesvirus 6 and 8 and was
10-fold less active against murine cytomegalovirus. Thus, WC5 may represent a lead for the development of new, potent, and selective anti-HCMV compounds.
Published ahead of print on 17 November 2008.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»